# Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia

> **NCT03033199** · PHASE2 · UNKNOWN · sponsor: **Shandong University** · enrollment: 60 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Probiotic Agent
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03033199
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-02
- **Final completion:** 2018-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033199, "Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03033199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*